Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
22 hedge funds and large institutions have $38.9M invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
292% more capital invested
Capital invested by funds: $9.92M → $38.9M (+$29M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 23 → 22 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
+$4.11M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$229K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$31.4K |
| 4 |
NC
Noked Capital
Tel Aviv,
Israel
|
+$16K |
| 5 |
NI
Noked Israel
Ramat Hasharon,
Israel
|
+$16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$107K |
| 2 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$30.9K |
| 3 |
LCG
Luxor Capital Group
New York
|
-$12.5K |
| 4 |
SC
Sculptor Capital
New York
|
-$11K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BHMP
26
Bardin Hill Management Partners
New York
| – | -$305 | -343 | -56% |
|
27
Morgan Stanley
New York
| – | +$111 | +125 | New |
|
CTV.WS Hedge Fund Activity: Q1 2022 in Review
22 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q1 2022, worth a combined $38.9M — up 292% from $9.92M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CTV.WS and 4 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 3 added.
The largest buyer was BAMCO Inc, adding an estimated $4.11M. The largest seller was Harel Insurance Investments & Financial Services, exiting entirely with an estimated $107K sold.
- 22 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q1 2022, down from 23 in Q4 2021.
- Funds reported $38.9M of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q1 2022, up 292% quarter-over-quarter.
- 4 funds opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q1 2022 and 5 closed out, a net change of -1 holder.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q1 2022 was BAMCO Inc, an estimated $4.11M added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q1 2022 was Harel Insurance Investments & Financial Services, an estimated $107K sold.
Based on aggregated 13F filings for Q1 2022.